Pura Vida Investments, LLC Eli Lilly & CO Call Options Transaction History

Pura Vida Investments, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $16.4 Million - $21.3 Million	-100,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $13 Million - $17.3 Million	100,000 New	100,000 $16.9 Million
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $2.65 Million - $2.97 Million	-25,000 Closed	0 $0
Q3 2018 Feb 11, 2021	BUY	$85.86 - $107.31 $2.13 Million - $2.66 Million	24,750 Added 9900.0%	25,000 $2.68 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $21,465 - $26,827	250 New	250 $8,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.